The Paediatric Obstructive Sleep Apnoea (OSA) Screening Triple Test (POSTT) Study: Validation of a novel home delivered paediatric OSA screening test.

Monash University0 个研究点目标入组 129 人开始时间: 2024年4月16日最近更新: 2024年4月22日

适应症

试验速览

暂无简介。

•a)Target Population: Australian children aged 2-16 years and at least one parent/guardian
•b)Sample Populations:
•- Patients, who have already been referred for PSG and fit inclusion criteria, will be recruited from each participating sleep centre.
•c)Study participants will be considered eligible for inclusion if they are aged between 2-16 years at the time of recruitment, and able to complete the POSTT within 4 weeks of PSG.

•Exclusion Criteria 1: Based on studies showing reduced accuracy of pulse oximetry testing in these populations, children with the following conditions will be excluded from the study:
•a.Neuromuscular disease,
•b.Congenital syndromes (e.g. Trisomy 21),
•c.Congenital heart diseases,
•d.Chronic lung disease requiring oxygen therapy,
•e.Previous trauma/burns to airway/face/neck,
•f.Weight <3rd or >95th centile for age
•Exclusion Criteria 2: Previous adenotonsillectomy (this renders tonsillar size component of index test non-contributory).

发起方